PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple sclerosis |
| Symptom | C0011570|depression |
| Sentences | 55 |
| PubMedID- 23783007 | Objectives: duloxetine hydrochloride, a dual reuptake inhibitor of serotonin and norepinephrine, was evaluated for its therapeutic efficacy, safety, and tolerability in the treatment of depression in patients with multiple sclerosis (ms). |
| PubMedID- 21948887 | Pathogenic mechanisms of depression in multiple sclerosis. |
| PubMedID- 26351621 | A brief description of the pathophysiology and effects of depression in patients with multiple sclerosis is also provided. |
| PubMedID- 20880067 | Stress and depression symptoms in patients with multiple sclerosis: the mediating role of the loss of social functioning. |
| PubMedID- 24501169 | Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis. |
| PubMedID- 24406031 | Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis. |
| PubMedID- 26445703 | Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires. |
| PubMedID- 26401158 | Prevalence and risk factors for depression in women with multiple sclerosis: a study from iran. |
| PubMedID- 25362584 | Effect of neurofeedback training on depression and fatigue in patients with multiple sclerosis. |
| PubMedID- 25603363 | Conclusion our study suggests that coq10 supplementation (500 mg/day) can improve fatigue and depression in patients with multiple sclerosis. |
| PubMedID- 19941048 | This study is a secondary analysis from a randomized clinical trial examining telephone-administered psychotherapy treatments for depression among patients with multiple sclerosis (please see mohr et al. |
| PubMedID- 21995045 | In our experiments, we demonstrate the robustness of our method by applying it to map hippocampal atrophy of multiple sclerosis patients with depression on a data set of 109 subjects. |
| PubMedID- 25061435 | Background: valid assessments are needed in order to identify anxiety and depression in people with multiple sclerosis (ms). |
| PubMedID- 23097716 | The present paper is focused on current knowledge on diagnosis, assessment, and therapeutic interventions for depression in the context of multiple sclerosis. |
| PubMedID- 25872520 | Results: higher depression scores of the parents with multiple sclerosis at baseline correlated with increased adolescents' internalising symptoms at 6-month follow-up (gammadep=0.31, p=.004). |
| PubMedID- 26155372 | Sexual dysfunction and depression in individuals with multiple sclerosis: is there a link. |
| PubMedID- 26008945 | Selective serotonin-reuptake inhibitors (ssris), commonly administered for depression and anxiety in patients with multiple sclerosis, are associated with qt interval prolongation. |
| PubMedID- 23754606 | Commentary on: predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study. |
| PubMedID- 25580882 | Disability identity predicts lower anxiety and depression in multiple sclerosis. |
| PubMedID- 25444450 | depression in multiple sclerosis. |
| PubMedID- 22168507 | Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial. |
| PubMedID- 25933976 | Zinc sulphate: a reasonable choice for depression management in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. |
| PubMedID- 26359900 | An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial. |
| PubMedID- 24852924 | depression in multiple sclerosis: a long-term longitudinal study. |
| PubMedID- 23244804 | Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life. |
| PubMedID- 24453767 | Attributional style and depression in multiple sclerosis: the learned helplessness model. |
| PubMedID- 23713732 | The co-occurrence of pain and depression in adults with multiple sclerosis. |
| PubMedID- 20070277 | Predictors of depression in multiple sclerosis patients. |
| PubMedID- 23438712 | Objective: the present study examined the relationship between volitional modes of coping (self-regulation, volitional inhibition, and self-control) and depression in individuals with multiple sclerosis. |
| PubMedID- 20663242 | Both social support and stress predict depression in multiple sclerosis (ms) patients. |
| PubMedID- 20812812 | Perceived social support and depression among veterans with multiple sclerosis. |
| PubMedID- 21621796 | Anxiety and depression in multiple sclerosis patients around diagnosis. |
| PubMedID- 20830648 | Assessment of depression in multiple sclerosis: development of a "trunk and branch" model. |
| PubMedID- 23812284 | Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. |
| PubMedID- 26453680 | Background: depression is common in patients with multiple sclerosis (ms), although the brain mechanisms of this psychiatric condition in ms are poorly understood. |
| PubMedID- 22527232 | Quality of life and depression in multiple sclerosis patients: longitudinal results of the betaplus study. |
| PubMedID- 26242758 | Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care hospital in oman. |
| PubMedID- 20809354 | The purpose of the study was to evaluate the prevalence of insomnia in multiple sclerosis patients with comorbid depression, associations between psychological symptoms, multiple sclerosis symptoms and insomnia, and to test effects of a 16-week protocol-based psychotherapy intervention for depression on insomnia symptoms. |
| PubMedID- 24653957 | Objective: the aim of this study was to investigate the course of alexithymia and its relation with anxiety and depression in patients with multiple sclerosis (ms), over a period of 5 years. |
| PubMedID- 23379265 | Telephone-based physical activity counseling for major depression in people with multiple sclerosis. |
| PubMedID- 19822449 | Fatigue and depression in children with multiple sclerosis and monophasic variants. |
| PubMedID- 26254948 | Objective: to evaluate the efficacy of a telephone-delivered self-management intervention for fatigue, pain, and depression in adults with multiple sclerosis (ms). |
| PubMedID- 22860028 | A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the uk ms register. |
| PubMedID- 23460394 | Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study. |
| PubMedID- 21432735 | depression in multiple sclerosis: reactive or endogenous. |
| PubMedID- 24926444 | forty sessions of ai chi aquatic exercise (ae) program improves pain, spasms, disability, fatigue, depression, and autonomy in patient with multiple sclerosis. |
| PubMedID- 20204955 | We assessed the applicability of ccbt for the treatment of depression in people with multiple sclerosis (ms). |
| PubMedID- 26223270 | depression in multiple sclerosis: the utility of common self-report instruments and development of a disease-specific measure. |
| PubMedID- 20007425 | depression is common in patients with multiple sclerosis, but to date no studies have explored diffusion tensor imaging indices associated with mood change. |
| PubMedID- 24559790 | Objective: the prevalence of depression in multiple sclerosis (ms) is known to be elevated, but nearly all available studies have estimated period prevalence. |
Page: 1 2